Procholecystokinin as marker of human Ewing sarcomas

Clinical Cancer Research

Volumn 10, Issue 16, 2004, Pages 5523-5530

  Reubi, Jean Claude ^a   Koefoed, Pernille ^b   Hansen, Thomas V O ^b   Stauffer, Edouard ^a   Rauch, Daniel ^c   Nielsen, Finn C ^b   Rehfeld, Jens F ^b,d  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c UNIVERSITY OF BERN   (Switzerland)

^d Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; BUSULFAN; CHOLECYSTOKININ; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOFOS; HORMONE PRECURSOR; IFOSFAMIDE; MELPHALAN; MESSENGER RNA; PROCHOLECYSTOKININ; TUMOR MARKER; UNCLASSIFIED DRUG; VINCRISTINE; VINCRISTINE SULFATE;

ADOLESCENT; ADULT; ARTICLE; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CCK GENE; CLINICAL ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; EWING SARCOMA; GENE; GENE EXPRESSION; HORMONE BLOOD LEVEL; HORMONE RELEASE; HORMONE SYNTHESIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREACTIVITY; IN SITU HYBRIDIZATION; MALE; PRIORITY JOURNAL; RADIOIMMUNOASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BONE NEOPLASMS; CELL LINE, TUMOR; CHOLECYSTOKININ; HUMANS; PROTEIN PRECURSORS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SARCOMA, EWING'S; TUMOR MARKERS, BIOLOGICAL;

EID: 4143153963     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-1015-03     Document Type: Article

References (20)

1. Walsh JH. Gastrin. In: Walsh JH, Dockray GJ, editors. Gut peptides: biochemistry and physiology. New York: Raven Press, 1994. p. 75-121.
2. Rehfeld JF. Processing of precursors of gastroenteropancreatic hormones: diagnostic significance. J Mol Med 1998;76:338-45.
3. Jensen RT, Pancreatic endocrine tumors: recent advances. Ann Oncol 1999;10(Suppl 4):S170-6.
4. Rehfeld JF, van Solinge WW. The tumor biology of gastrin and cholecystokinin. Adv Cancer Res 1994;63:295-347.
5. Schaer JC, Reubi JC. High gastrin and cholecystokinin (CCK) gene expression in human neuronal, renal and myogenic stem cell tumors: comparison with CCK-A and CCK-B receptor content. J Clin Endocrinol Metab 1999;84:233-9.
6. Friedman JM, Vitale M, Maimon J, Israel MA, Horowitz ME, Schneider BS. Expression of the cholecystokinin gene in pediatric tumors. Proc Natl Acad Sci USA 1992;89:5819-23.
7. Grier HE. The Ewing family of tumors. Pediatr Oncol 1997;44:991-1004.
8. McManus AP, Gusterson BA, Pinkerton CR, Shipley JM. The molecular pathology of small round-cell tumours-relevance to diagnosis, prognosis, and classification. J Pathol 1996;178:116-21.
9. Aurias A, Rimbaut C, Buffe D, Dubousset J, Mazabraud A. Chromosomal translocations in Ewing's sarcoma. N Engl J Med 1983;309: 496-8.
10. Turc-Carel C, Aurias A, Mugneret F, et al. Chromosomes in Ewing's sarcoma. I. An evaluation of 85 cases of remarkable consistency of t(11;22)(p24;q12). Cancer Genet Cytogenet 1988;32:229-38.
11. Fletcher JA. Ewing's sarcoma oncogene structure: a novel prognostic marker? J Clin Oncol 1998;16:1241-3.
12. Zucman J, Melot T, Desmaze C, et al. Combinatorial generation of variable fusion proteins in the Ewing family of tumours. EMBO J 1993;12:4481-7.
13. Schajowicz F. Histological typing of bone tumours, second edition. Berlin: Springer-Verlag, 1993. p. 128.
14. Paloheimo LI, Rehfeld JF. A processing-independent assay for human procholecystokinin and its products. Clin Chim Acta 1994;229: 49-65.
15. Paloheimo LI, Rehfeld JF. Quantitation of procholecystokinin and its products in plasma by processing-independent analysis. Clin Chim Acta 1995;238:21-33.
16. Rehfeld JF. Accurate measurement of cholecystokinin in plasma. Clin Chem 1998;44:991-1001.
17. Rehfeld JF, Sun G, Christensen T, Hillingso JG. The predominant cholecystokinin in human plasma and intestine is cholecystokinin-33. J Clin Endocrinol Metab 2001;86:251-8.
18. Bardram L, Rehfeld JF. Processing-independent radioimmuno-analysis: a general analytical principle applied to progastrin and its products. Anal Biochem 1988;175:537-43.
19. Koh TJ, Dockray GJ, Varro A, et al. Overexpression of glycine-extended gastrin in transgenic mice results in increased colonic proliferation. J Clin Investig 1999;103:1119-26.
20. Wang TC, Dangler CA, Chen D, et al. Synergistic interaction between hypergastrinemia and helicobacter infection in a mouse model of gastric cancer. Gastroenterology 2000;118:36-47.